Age at menarche is considered a weak predictor of ovarian cancer risk. A moderate increase in risk for ovarian cancer occurs in women when menarche begins earlier than age 12 years. [1,15] No ...

Ovarian cancer remains one of the most challenging gynaecological cancers to detect and treat. While there is no definitive ...

Risk factors for ovarian cancer include: Being age 60 or older A family history breast cancer or ovarian cancer Having children later in life or never having a full-term pregnancy Taking hormone ...

Risk factors – include Metabolic syndrome, obesity, diabetes, hormonal imbalance, polycystic ovarian disease, inability to have children, delaying childbirth. Family history of uterine cancer ...

Breast cancer is among the most common malignant tumors affecting women worldwide, arising from a complex mix of genetic, ...

Data presented as part of a poster at the SITC 2024 ConferenceSOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics ...

Even though ovarian cancer is not one of the most common women’s cancers ... aspirin use is linked with lower ovarian cancer risk in people with multiple risk factors... Shelli Armstrong was diagnosed ...

The Breast and Ovarian Cancer Prevention (BOCP ... Information about hereditary (passed down in your family) and nonhereditary breast or gynecological cancer risk factors Ways to lower your breast or ...

The study used Cox proportional hazards models, adjusting for various risk factors, to analyze the relationship between air pollution and ovarian cancer. Limitations include the inability to ...

A new study found that women who used levonorgestrel-releasing IUDS are at a slightly higher risk of developing breast cancer ...

In this study, the Cancer Research UK-funded scientists will establish the targets for the vaccine. They will find out which proteins on the surface of early-stage ovarian cancer cells are most ...

Nurses collect data from women and their families that may contribute to refining the risk factors for ovarian cancer and possibly identifying high-risk subgroups susceptible to these tumors.